GluN2A mediates ketamine-induced rapid antidepressant-like responses.
Tonghui Su, Yi Lu, Chaoying Fu, Yang Geng, Yelin Chen
Nature Neuroscience September 14, 2023 DOI: 10.1038/s41593-023-01436-y (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal study (mouse) Peer reviewed |
|---|---|
| Population | Adult mice (hippocampal principal neurons) |
| Interventions | Ketamine MK-801 (dizocilpine) |
| Topics | Ketamine Esketamine |
| Keywords | Hippocampus Neurons Animals Mice Dizocilpine maleate Receptors, n-methyl-d-aspartate Antidepressive agents |
| Key points | Loss of the GluN2A NMDA receptor subunit in adult mouse brains produced antidepressant-like behavioral responses with limited impact on behaviors mimicking ketamine's psychotomimetic effects. The antidepressant-like effects of ketamine and MK-801 were mediated by suppression of GluN2A, not inhibition of GluN2B, and both drugs rapidly increased hippocampal principal neuron excitability through GluN2A. The authors conclude that GluN2A mediates ketamine-triggered rapid antidepressant-like responses. |
Abstract
Ketamine was thought to induce rapid antidepressant responses by inhibiting GluN2B-containing N-methyl-D-aspartic acid (NMDA) receptors (NMDARs), which presents a promising opportunity to develop better antidepressants. However, adverse side effects limit the broader application of ketamine and GluN2B inhibitors are yet to be approved for clinical use. It is unclear whether ketamine acts solely through GluN2B-dependent mechanisms. The present study reports that the loss of another major NMDAR subunit, GluN2A, in adult mouse brains elicits robust antidepressant-like responses with limited impact on the behaviors that mimic the psychomimetic effects of ketamine. The antidepressant-like behavioral effects of broad NMDAR channel blockers, such as ketamine and MK-801 (dizocilpine), were mediated by the suppression of GluN2A, but not by the inhibition of GluN2B. Moreover, treatment with ketamine or MK-801 rapidly increased the intrinsic excitability of hippocampal principal neurons through GluN2A, but not GluN2B. Together, these findings indicate that GluN2A mediates ketamine-triggered rapid antidepressant-like responses.
Comparable studies
Other preclinical and animal studies on ketamine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Rats | 2010 | Observational study | |
| Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Conscious rats | 1997 | Dose-response study with microdialysis and behavioral testing | |
| NMDAR inhibition-independent antidepressant actions of ketamine metabolites Mice | 2016 | Preclinical study | |
| The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate Spinal neurons in decerebrate or pentobarbitone-anaesthetized cats and rats | 1983 | Experimental study | |
| R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects Mice | 2015 | Experimental study |
Citations in the library
Cited by 23
- Brain region-specific action of ketamine as a rapid antidepressant. Science August 9, 2024
- Adenosine signalling drives antidepressant actions of ketamine and ECT Nature November 5, 2025
- Activity in the dorsal hippocampus-mPFC circuit modulates stress-coping strategies during inescapable stress. Experimental & molecular medicine September 1, 2024
- Psychoactive substances for the treatment of neuropsychiatric disorders. Asian Journal of Psychiatry November 1, 2024
- Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential. Aging and disease April 29, 2024
and 18 more in the library
Cites 14
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Science August 19, 2010
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites Nature April 24, 2016
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms Pharmacological Reviews June 26, 2018
- GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions. Journal of Clinical Investigation November 19, 2019
- Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide F1000Research May 24, 2018
and 9 more in the library